NCT02681458

Brief Summary

The purpose of this study was about survey of prevalence of fungal infections among drug users referring to methadone wards of Hospitals in northeast region of Iran

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,436

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2013

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2013

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2014

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

January 31, 2016

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 12, 2016

Completed
3 months until next milestone

Results Posted

Study results publicly available

May 20, 2016

Completed
Last Updated

May 20, 2016

Status Verified

April 1, 2016

Enrollment Period

7 months

First QC Date

January 31, 2016

Results QC Date

March 15, 2016

Last Update Submit

April 13, 2016

Conditions

Skin and Subcutaneous Tissue Fungal Infections

Outcome Measures

Primary Outcomes (1)

  • The Prevalence of Superficial and Cutaneous Fungal Infections Among Drug and Non-Drug Users

    up to two months

Study Arms (2)

Drug Users

Case group that consisted of drug users with fungal infections

Other: Direct Examination

Non-drug Users

Control group that consisted of non drug users with fungal infections

Other: Direct Examination

Interventions

Direct ExaminationOTHER

It was an observational study and subjects received their routine treatment.

Drug UsersNon-drug Users

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

people from northeast region of Iran referring to Methadone clinics. there were no limitations of age and sex.

You may qualify if:

  • Suspected fungal lesions

You may not qualify if:

  • non use of local or edible anti-fungal drugs and not taking bath within the last 48 hours of testing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Islamic Azad University of Mashhad

Mashhad, Khorasan Razavi, Iran

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

hair, nail, cutaneous lesions

Results Point of Contact

Title
Dr. Hassan Yazdanfar
Organization
Islamic Azad University of Mashhad
hasanyazdanfar@yahoo.com
00985136631004

Study Officials

  • Hassan Yazdanfar, MD, PhD

    assistant professor of mycology and parasitology

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of parasitology and mycology department

Study Record Dates

First Submitted

January 31, 2016

First Posted

February 12, 2016

Study Start

August 1, 2013

Primary Completion

March 1, 2014

Study Completion

April 1, 2014

Last Updated

May 20, 2016

Results First Posted

May 20, 2016

Record last verified: 2016-04

Locations

IR(1)